Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bridging integrator 2 pseudogene 1 (BIN2P1)
- Target
- BIN2P1
- Molecular classification
- Pseudogene, Other
01
Overview
Bridging integrator 2 pseudogene 1 (BIN2P1) is a non-coding genetic sequence derived from the parental BIN2 gene. BIN2P1 does not encode a functional protein, and there is no evidence that it serves as a receptor or molecular target in therapeutics or drug discovery. Pseudogenes like BIN2P1 may regulate gene expression by acting as ‘decoys’ for microRNAs or producing regulatory small RNAs, though these roles are well-characterized only for a small subset of pseudogenes. Direct links between BIN2P1 and disease, drug interaction, or biomarker status have not been demonstrated in the scientific literature[1][2][3].
02
Mechanism of action
None known for BIN2P1. Generic pseudogene mechanisms (for reference) include: miRNA ‘decoy’/ceRNA interactions (regulating expression of parental genes by sponging miRNAs); siRNA production (RNA interference of homologous genes)
03
Biological functions
Competing endogenous RNA (ceRNA) activity or microRNA ‘decoy’Possible regulation of mRNA stabilitysiRNA generation
04
Disease associations
Other (For some pseudogenes, dysregulation has been linked to diseases like cancer, diabetes, but there is NO evidence linking BIN2P1 specifically to any disease)
05
Safety considerations
Therapeutic challenges apply to pseudogene-targeted approaches generally, such as delivery, specificity, and off-target effects.
Beyond the preview
Go deeper on Bridging integrator 2 pseudogene 1 (BIN2P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bridging integrator 2 pseudogene 1 (BIN2P1).